Caricamento...

Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome

PURPOSE: To assess the anatomical outcome of patients with exudative age-related macular degeneration resistant to ranibizumab treated with aflibercept. METHOD: Prospective, interventional, case series, where we treated a group of patients deemed resistant to Ranibizumab after 6 months of persistenc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Saudi J Ophthalmol
Autore principale: Abou-Ltaif, Sleiman
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161818/
https://ncbi.nlm.nih.gov/pubmed/28003780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjopt.2016.10.008
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !